Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02887976
Title Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors GU Research Network, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.